Xizeng Hui
Papers
1
Total Citations
4
H-Index
1
About
Xizeng Hui is a leading clinical researcher in gastrointestinal oncology, with a focused expertise in the perioperative management of gastric cancer patients. His work centers on optimizing surgical outcomes through innovative, evidence-based interventions, particularly for patients with advanced disease. Dr. Hui’s major contribution is the design and leadership of the GISSG2023-01 Study, a landmark multicenter randomized controlled trial investigating the effect of perioperative probiotic supplements on short-term clinical outcomes following laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy. This research addresses a critical gap in supportive care, aiming to mitigate the gut dysbiosis induced by chemotherapy and surgery to reduce complications and enhance recovery. His most cited paper (2025, 4 citations) has already garnered attention for its rigorous methodology and potential to reshape postoperative protocols. By integrating probiotics into the surgical pathway, Dr. Hui is pioneering a low-cost, high-impact strategy to improve prognoses for patients with advanced gastric cancer, demonstrating a commitment to translating mechanistic insights into tangible clinical benefits.
Research Focus
Key Achievements
Top Papers
- 1